FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
7 letters match. Newest first.
-
DrugsPinnacle Professional Research dba Pinnacle Peptides
FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.
High risk -
DrugsZhejiang Huahai Pharmaceutical Co., Ltd.
FDA warns Zhejiang Huahai Pharmaceutical over CGMP violations including dirty equipment, aseptic-area tape, and data integrity issues.
High risk -
DrugsIntercos Europe S.p.A
FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.
High risk -
DrugsWestwood Laboratories LLC
FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.
High risk -
DrugsMaggie Jeffries, M.D. / Avanti Anesthesiology, LLC
FDA warns Houston clinical investigator Dr. Maggie Jeffries for running drug trials without an IND and with informed-consent failures.
High risk -
Drugsglobalpharmacyplus.com
FDA warned globalpharmacyplus.com in Canada for selling unapproved and misbranded prescription drugs to U.S. consumers online.
High risk -
DrugsToyobo Co. Ltd.
FDA warned Toyobo after inspection found unresolved particulate contamination and environmental monitoring data manipulation affecting sterile injectable drugs.
High risk